A breakthrough dual-action medication that supports appetite regulation and promotes lasting weight reduction.
Tirzepatide is a once-weekly injectable that activates both GLP-1 and GIP receptors — two pathways that together help regulate appetite, blood sugar, and metabolism. For many patients, that means less food noise, better satiety, and consistent, sustainable weight loss.
Includes provider visit, medication, and follow-up support. Members save 10%.
It mimics two natural gut hormones (GLP-1 and GIP) that regulate appetite, slow gastric emptying, and improve insulin sensitivity. The result is reduced hunger, fewer cravings, and meaningful weight loss for most patients.
Once a week via a small subcutaneous injection — usually self-administered at home after our team trains you.
Mild GI symptoms (nausea, fullness, occasional constipation) are most common, especially during dose escalation. Most resolve as your body adjusts. Our team monitors you throughout.
That depends on your goals. Many patients use it for 6–18 months, then transition to a maintenance plan with our providers.
Book your initial consultation and bloodwork — most patients can start treatment within a week.
Book Consultation
TrueWeightLoss